Intra-Cellular Therapies to Present Data on its Novel Compound ITI-333

http://ir.intracellulartherapies.com/common/mobile/iphone/releasedetail.cfm?ReleaseID=1026973&CompanyID=AMDA-2O83FW&MobileID=

This unique pharmacological profile is predicted to translate into clinical utility to address symptoms associated with mood disorders and substance abuse, with particular potential importance for patients with both substance use disorders and psychiatric comorbidities including depression and anxiety

2 Likes

What it.s for positive or negative. …ever…hopeful

Mood disorders.

1 Like